Overview

A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The study objectives are to evaluate Tonsitin™ (10% Lactic Acid) safety, tolerability and preliminary efficacy, as a potent treatment for Recurrent Tonsillitis in children.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Yali Pharmaceuticals